Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study.

MLA

Herman, S. E. M., et al. “Ibrutinib-Induced Lymphocytosis in Patients with Chronic Lymphocytic Leukemia: Correlative Analyses from a Phase II Study.” Leukemia, vol. 28, no. 11, Nov. 2014, pp. 2188–96. EBSCOhost, https://doi.org/10.1038/leu.2014.122.

APA

Herman, S. E. M., Niemann, C. U., Farooqui, M., Jones, J., Mustafa, R. Z., Lipsky, A., Saba, N., Martyr, S., Soto, S., Valdez, J., Gyamfi, J. A., Maric, I., Calvo, K. R., Pedersen, L. B., Geisler, C. H., Liu, D., Marti, G. E., Aue, G., & Wiestner, A. (2014). Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study. Leukemia, 28(11), 2188–2196. https://doi.org/10.1038/leu.2014.122

Chicago

Herman, S E M, C U Niemann, M Farooqui, J Jones, R Z Mustafa, A Lipsky, N Saba, et al. 2014. “Ibrutinib-Induced Lymphocytosis in Patients with Chronic Lymphocytic Leukemia: Correlative Analyses from a Phase II Study.” Leukemia 28 (11): 2188–96. doi:10.1038/leu.2014.122.